Literature DB >> 9818859

Central poststroke pain: correlation of MRI with clinical pain characteristics and sensory abnormalities.

D Bowsher1, G Leijon, K A Thuomas.   

Abstract

OBJECTIVE: To correlate MRI and sensory changes in patients with spontaneous lesions in the cerebral "pain pathway."
METHODS: The authors used MRI and quantitative somatosensory testing in 73 patients with central poststroke pain (CPSP) and in 13 patients with pain-free stroke with sensory deficit.
RESULTS: Lesions in any part of the discriminatory somatosensory pathway may or may not produce CPSP. Most CPSP patients have multiple lesions, many probably unrelated to pain. Ventroposterior thalamic nuclear lesions are more likely to produce half-body pain than lesions elsewhere (including the brainstem). In supratentorial lesions, the greatest pain is more likely to be in an extremity, and in infratentorial lesions, the greatest pain is likely to be in the face. Supratentorial CPSP patients have a deficit of sharpness and cold (peripherally mediated by A delta fibers) than pain-free stroke patients, whereas patients with infratentorial CPSP additionally have a deficit of C-fiber-mediated warmth and hot pain. Burning pain is more common than nonburning pain in younger patients. Warmth and cold, but not hot pain, exhibiting central convergence (spatial summation) are more affected in CPSP patients with burning than nonburning pain. Allodynic CPSP patients had a significantly greater deficit for warmth than patients without allodynia.
CONCLUSIONS: Different stroke sites produce different patterns of sensory deficit. The progression from painless sensory deficit to CPSP is not purely quantitative.

Entities:  

Mesh:

Year:  1998        PMID: 9818859     DOI: 10.1212/wnl.51.5.1352

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  19 in total

Review 1.  Neurological diseases and pain.

Authors:  David Borsook
Journal:  Brain       Date:  2011-11-08       Impact factor: 13.501

Review 2.  Modulating the pain network--neurostimulation for central poststroke pain.

Authors:  Koichi Hosomi; Ben Seymour; Youichi Saitoh
Journal:  Nat Rev Neurol       Date:  2015-04-21       Impact factor: 42.937

Review 3.  Pharmacological management of central post-stroke pain: a practical guide.

Authors:  Jong S Kim
Journal:  CNS Drugs       Date:  2014-09       Impact factor: 5.749

4.  Altered pain and thermal sensation in subjects with isolated parietal and insular cortical lesions.

Authors:  D S Veldhuijzen; J D Greenspan; J H Kim; F A Lenz
Journal:  Eur J Pain       Date:  2009-11-25       Impact factor: 3.931

Review 5.  Brain modules of hallucination: an analysis of multiple patients with brain lesions.

Authors:  Claude M J Braun; Mathieu Dumont; Julie Duval; Isabelle Hamel-Hébert; Lucie Godbout
Journal:  J Psychiatry Neurosci       Date:  2003-11       Impact factor: 6.186

Review 6.  Pain management in neurocritical care.

Authors:  Axel Petzold; Armand Girbes
Journal:  Neurocrit Care       Date:  2013-10       Impact factor: 3.210

Review 7.  Demystifying Poststroke Pain: From Etiology to Treatment.

Authors:  Andrew K Treister; Maya N Hatch; Steven C Cramer; Eric Y Chang
Journal:  PM R       Date:  2016-06-16       Impact factor: 2.298

8.  Analgesia in conjunction with normalisation of thermal sensation following deep brain stimulation for central post-stroke pain.

Authors:  Anthony E Pickering; Simon R Thornton; Sarah J Love-Jones; Charlotte Steeds; Nikunj K Patel
Journal:  Pain       Date:  2009-10-14       Impact factor: 6.961

9.  Alteration of White Matter in Patients with Central Post-Stroke Pain.

Authors:  Jung Geun Park; Bo Young Hong; Hae-Yeon Park; Yeun Jie Yoo; Mi-Jeong Yoon; Joon-Sung Kim; Seong Hoon Lim
Journal:  J Pers Med       Date:  2021-05-15

10.  Central poststroke pain: somatosensory abnormalities and the presence of associated myofascial pain syndrome.

Authors:  Rogério Adas Ayres de Oliveira; Daniel Ciampi de Andrade; André Guelman Gomes Machado; Manoel Jacobsen Teixeira
Journal:  BMC Neurol       Date:  2012-09-11       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.